Human Exceptionalism

I Was Right About Diabetes Story: No Big Headlines, Only Muted Coverage

Yesterday, I wrote about a diabetes human trial using adult stem cells in which some of the patients were able to go off insulin. I predicted at the time that it wouldn’t make big time headlines–as would happen if the exact same achievement happened with human patients using embryonic stem cells: From my blog:

We know that if this were an embryonic stem cell success, the headlines would swamp reportage of the financial crisis. But this is the wrong kind of stem cell success, so I expect, at most, muted coverage.

That’s precisely what it received, muted coverage. New York Times; crickets chirping. Ditto, the Washington Post. And ditto again, the L.A. Times. No Boston Globe. No San Francisco Chronicle. Some on-line coverage in health and science publications. CNN had a small story. Time did too, not big though. Just what I expected. Hey, it did make the Times of India!

You see, successful human treatments don’t count as news if they are from adult stem cells. That doesn’t fit the media narrative that ESCR is the future. That is why a prospective Geron ESC human trial that might or might not work, got more coverage than these stories of an actual major success did put together.

Pathetic, biased, non journalism. Just pathetic.

Most Popular


Weirdo O’Rourke

Friends of the young Bill Clinton and Barack Obama spoke of the special glow of promise they had about them, even back in their early twenties. Angels sat on their shoulders. History gave them a wink and said, “Hey, good lookin’, I’ll be back to pick you up later.” Robert O’Rourke? Not so much. He ... Read More

McCain at Annapolis

President Trump has been doing a lot of tweeting today -- against TV programs, companies, and other things that have incurred his displeasure. These tweets make for interesting reading. One of them is this: So it was indeed (just proven in court papers) “last in his class” (Annapolis) John McCain that sent ... Read More